Institutional Ownership
Galectin Therapeutics Inc
CUSIP 363225202COM NEWGALTQ1 2026
Institutional Holders
95
13F filers
Shares Held
11.58M
Aggregate institutional
Institutional Value
$31.44M
Q1 2026
Net New Holders
+1
16 new · 15 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions16
Increased31
Decreased23
Sold out15
Institutional Holders
95 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Marshall Wace, LLP | 1.22M | $3.40M | +617.8K | Added |
| 2 | Osaic Holdings, Inc. | 1.12M | $3.13M | +32.1K | Added |
| 3 | Blackrock, Inc. | 799.2K | $2.23M | +2.7K | Added |
| 4 | Millennium Management LLC | 798.4K | $2.23M | +562.9K | Added |
| 5 | Wealthspire Advisors, LLC | 721.8K | $2.01M | +119.8K | Added |
| 6 | Geode Capital Management, LLC | 612.8K | $1.71M | +14.7K | Added |
| 7 | Susquehanna International Group, LLP | 555.7K | $1.55M | +268.8K | Added |
| 8 | Two Sigma Investments, LP | 467.1K | $1.30M | +450.5K | Added |
| 9 | Commonwealth Equity Services, LLC | 367.1K | $1.02M | +33.0K | Added |
| 10 | Citadel Advisors LLC | 290.4K | $810.1K | +290.4K | New |
85 more institutional holders on Premium
See every fund holding Galectin Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders